Karen Owen Gibbs joined McDermott in 2014 after serving as Vice President and Senior Counsel at CVS Health (formerly CVS Caremark), a Fortune 20 integrated pharmacy company. Karen advises a wide variety of health care companies, investors and lenders on operational, regulatory and enforcement issues related to all aspects of the pharmacy distribution chain. Her practice also covers synergistic areas such as substance abuse/behavioral health, physician and veterinarian office dispensing, evolving requirements related to opioid prescribing and dispensing, and a wide variety of prescription reimbursement issues.
Karen has an extensive background in licensing, regulatory, compliance, enforcement and policy issues in the health care and life sciences industries, including pharmacies (specialty, mail, retail, institutional and long-term care), pharmaceutical and biologics manufacturers, pharmacy benefit management (PBM) companies, wholesaler/distributors, behavioral health companies, institutional health care providers, and prescription drug plans. With McDermott’s FDA team, Karen has offered guidance on compounding pharmacy issues, re-packager issues, and compliance with the Drug Quality and Security Act.
In addition to transactional and regulatory work, Karen’s recent representations include internal investigations and enforcement actions related to pharmacy law issues, Drug Enforcement Administration (DEA) and related state issues such as reporting under the Prescription Drug Monitoring Program (PDMP) requirements, and reimbursement issues.
Education
University of Virginia School of Law, JD, 1992
University of Virginia, MA, 1989
Georgetown University, BSFS, 1987
Admissions
Illinois
Associée | Chicago
Chicago: +1 312 984 3652
Chicago: +1 312 276 9496
New York, NY / McDermott Event / October 25,2019
Washington, DC / Speaking Engagements / May 30, 2019
Special Report / January 19, 2017
San Francisco, California / McDermott Event / January 10, 2017
On the Subject / December 22, 2016
On the Subject / December 14, 2016
On the Subject / November 14, 2016
On the Subject / November 7, 2016
On the Subject / July 22, 2016
On the Subject / March 31, 2016
On the Subject / March 15, 2016
On the Subject / March 15, 2016
On the Subject / October 2, 2015
On the Subject / July 15, 2015
On the Subject / July 1, 2015
On the Subject / April 23, 2015
On the Subject / January 8, 2015
On the Subject / October 8, 2014
On the Subject / September 24, 2014
On the Subject / May 5, 2014
1
2
3
4
New York / Press Releases / October 24, 2019
New York / Press Releases / October 10, 2019
McDermott Convenes Hottest Dealmakers At Private Equity Forum
Law.com / The American Lawyer / December 4, 2017
BioPharma Dive / December 15, 2016
FDA Guidance Urges Vigilance to Fight Suspect Products in Drug Supply Chain
PogoWasRight.org [privacy blog] / November 15, 2016
Ninth Circuit Considers Limits to DEA Access to Oregon Prescription Drug Monitoring ...
Pro Bono News / September 6, 2016
Eleven McDermott Health Lawyers Named AHLA Pro Bono Champions
Legal Newsline / May 18, 2016
Massachusetts Taking Different Tactic on Opioid Addiction by Limiting Prescription Supply
National Law Journal / March 10, 2014
Bloomberg Businessweek / February 20, 2014
McDermott Will, Quarles & Brady, Shearman Make Lateral Hires
The American Lawyer / February 19, 2014
Law360 / February 18, 2014
/ February 18, 2014
McDermott Adds Prominent Health Regulatory and Compliance Partner in Chicago
1
2
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.
